SQZ Biotechnologies Co (SQZB)

[crudeoil24]

SQZ Gets Fast-Track Designation for Tumor Treatment, Shares Rise 16%
5:21 pm ET April 27, 2022 (Dow Jones) Print

By Stephen Nakrosis


Shares of SQZ Biotechnologies Co. were trading higher in Wednesday's after-hours market following news the Food and Drug Administration gave fast-track designation for the company's lead cell therapy candidate, SQZ-PBMC-HPV.

SQZ-PBMC-HPV is being evaluated to treat HPV16+ advanced or metastatic solid tumors.

At 5:09 p.m. EDT, the company's stock had risen 16.97% to trade at $3.24 per share. The stock finished the day's regular session with a 5.14% loss, closing at $2.77 per share.

The FDA said fast track is a process "designed to facilitate the development, and expedite the review of drugs to treat serious conditions and fill an unmet medical need."


Write to Stephen Nakrosis at [e-mail]


(END) Dow Jones Newswires

April 27, 2022 17:21 ET (21:21 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.